Easy access to vaccination was important for adherence during the 2016-2019 HPV catch-up vaccination in Norway

被引:0
|
作者
van Boetzelaer, E. [1 ,2 ]
Daae, A. [1 ]
Winje, B. A. [1 ]
Vestrheim, D. F. [1 ]
Steens, A. [1 ]
Stefanoff, P. [1 ]
机构
[1] Norwegian Inst Publ Hlth, Dept Vaccine Preventable Dis, Oslo, Norway
[2] Field Epidemiol Path EPIET, ECDC Fellowship Program, Stockholm, Sweden
关键词
Papilloma virus infections; vaccination; immunization programs; communication; human papillomavirus; cross-sectional studies; vaccination initiation; vaccination adherence; adolescent vaccination; HUMAN-PAPILLOMAVIRUS VACCINATION; IMPLEMENTATION; DETERMINANTS; ADOLESCENTS; CHALLENGES; EFFICACY;
D O I
10.1080/21645515.2021.1971921
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Between September and October 2019, the Norwegian Institute for Public Health (NIPH) surveyed women born between 1991 and 1996 who were offered catch-up vaccination for human papilloma virus (HPV). The aim was to identify determinants of vaccine schedule adherence. A random sample of 10,000 women who were offered catch-up vaccination were invited to participate in the survey. We defined adherence as receiving all three doses. Determinants of HPV vaccination adherence were investigated using descriptive, univariable and multivariable logistic regression analyses providing adjusted odds ratios (aOR). Data from 3,762 respondents who received at least one dose were included. Overall, 92.1% (95% CI = 89.3-91.9) of those initiating vaccination adhered to the complete schedule. The following factors were significantly associated with HPV vaccination adherence compared to non-adherence: country of origin (aOR = 0.43; 95% CI = 0.47-0.97), having children (aOR = 0.51; 95% CI = 0.35-0.73), ease of finding out where to get vaccinated (aOR = 1.94; 95% CI = 1.69-2.23), preference for receiving information from health authorities (aOR = 1.37; 95% CI = 1.04-1.81) and vaccination being readily available (aOR = 2.28; 95% CI = 1.50-3.37). Information from NIPH via SMS and social media were negatively associated for Norwegians (aOR = 0.68, 95% CI = 0.46-1.01) and positively associated for those whose country of origin was not Norway (aOR = 1.48, 95% CI = 0.69-3.14; not significant). Those who did not adhere to the full vaccination schedule reported that they had forgotten (40.4%; 95% CI = 33.5-47.8) or had no time (32.9%; 95% CI = 26.2-40.4). Despite NIPH's targeted communication campaign, the main barriers for HPV vaccination adherence were difficulty to find out where to get the vaccine, forgetting to take the vaccine or not having time to complete the schedule.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Sociodemographic determinants of catch-up HPV vaccination completion between 2016-2019 in Norway
    Van Boetzelaer, E.
    Daae, A.
    Winje, B. A.
    Vestrheim, D. F.
    Steens, A.
    Stefanoff, P.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [2] Access to Catch-Up HPV Vaccination among Latina University Students
    Clevenger, Lesly-Marie
    Dreisbach, Susan
    Scandlyn, Jean N.
    Brett, John
    HUMAN ORGANIZATION, 2012, 71 (01) : 44 - 53
  • [3] Intentions for catch-up HPV vaccination in Japan: an internet survey
    Satoshi Nakagawa
    Asami Yagi
    Yutaka Ueda
    Sayaka Ikeda
    Mamoru Kakuda
    Kosuke Hiramatsu
    Ai Miyoshi
    Toshihiro Kimura
    Kei Hirai
    Masayuki Sekine
    Tomio Nakayama
    Eiji Kobayashi
    Etsuko Miyagi
    Takayuki Enomoto
    Tadashi Kimura
    International Journal of Clinical Oncology, 2023, 28 : 1667 - 1679
  • [4] Intentions for catch-up HPV vaccination in Japan: an internet survey
    Nakagawa, Satoshi
    Yagi, Asami
    Ueda, Yutaka
    Ikeda, Sayaka
    Kakuda, Mamoru
    Hiramatsu, Kosuke
    Miyoshi, Ai
    Kimura, Toshihiro
    Hirai, Kei
    Sekine, Masayuki
    Nakayama, Tomio
    Kobayashi, Eiji
    Miyagi, Etsuko
    Enomoto, Takayuki
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (12) : 1667 - 1679
  • [5] Problems with catch-up HPV vaccination after resumption of proactive recommendations
    Sekine, Masayuki
    Yamaguchi, Manako
    Kudo, Risa
    Hanley, Sharon J. B.
    Ueda, Yutaka
    Kurosawa, Megumi
    Adachi, Sosuke
    Miyagi, Etsuko
    Hara, Megumi
    Enomoto, Takayuki
    LANCET ONCOLOGY, 2022, 23 (08): : 972 - 973
  • [6] Is the catch-up program of HPV vaccination for Japanese adult women effective or not?
    Kurokawa, Tetsuji
    CANCER SCIENCE, 2020, 111 (04) : 1435 - 1436
  • [7] HPV CATCH-UP VACCINATION AMONG A COMMUNITY SAMPLE OF YOUNG ADULT WOMEN
    Manhart, L.
    Burgess-Hull, A.
    Fleming, C.
    Bailey, J.
    Haggerty, K.
    Catalano, R.
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A338 - A338
  • [8] Opportunity for catch-up HPV vaccination in young women after first delivery
    Rama, Cristina Helena
    Villa, Luisa L.
    Pagliusi, Sonia
    Andreoli, Maria A.
    Costa, Maria C.
    Thomann, Patricia
    Alves, Venancio A. F.
    Longatto-Filho, Adhemar
    Eluf-Neto, Jose
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2010, 64 (07) : 610 - 615
  • [9] Sociodemographic Correlates of Human Papillomavirus Vaccine Uptake: Opportunistic and Catch-Up Vaccination in Norway
    Dong, Li
    Nygard, Mari
    Hansen, Bo T.
    CANCERS, 2021, 13 (14)
  • [10] HPV catch-up vaccination of young women: a systematic review and meta-analysis
    Couto, Elisabeth
    Saeterdal, Ingvil
    Juvet, Lene Kristine
    Klemp, Marianne
    BMC PUBLIC HEALTH, 2014, 14